OPTIMIZING NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS SEVERITY USING PRO-C3/ADAPT INDEX IN PATIENTS WITH MASLD. YHCĐ. 2026;67(CD14). doi:10.52163/yhc.v67iCD14.6447